{
    "nct_id": "NCT06024096",
    "official_title": "Systems Biological Assessment of Statin Effect on Vaccine Responses",
    "inclusion_criteria": "* Able to understand and give informed consent.\n* Age 18-50 years.\n* Women of childbearing potential must agree to use effective birth control for the first 3 months of the study. A negative urine pregnancy test must be documented prior to vaccination.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 50 Years",
    "exclusion_criteria": "* History of allergy or serious adverse reaction, including Guillain-BarrÃ© syndrome, to a vaccine or vaccine products.\n* History of a medical condition resulting in impaired immunity such as active solid tumors, leukemia, lymphoma, use of immunosuppressive drugs, chemotherapy, or radiation therapy. Persons with previous skin cancers or cured non-lymphatic tumors are not excluded from the study.\n* History of HIV, Hepatitis B, or Hepatitis C infection.\n* Chronic clinically significant medical problems that could be considered active or unstable (i.e. diagnosed within the past 3 months or requiring a change in medication within the past 3 months). This includes (but is not limited to):\n\n  1. Insulin-dependent diabetes\n  2. Severe heart disease (including arrhythmias)\n  3. Severe lung disease\n  4. Severe liver disease\n  5. Severe kidney disease\n  6. Severe hypertension: defined as life-threatening consequences (e.g., malignant hypertension, transient or permanent neurologic deficit).\n* BMI > 30\n* Current or previous use of statins or any other lipid-lowering drug.\n* Pregnancy or breastfeeding or plans to become pregnant in the first 3 months of study participation.\n* History of influenza infection within the same influenza season.\n* Receipt of blood products or immune globulin products within the prior 3 months.\n* History of excessive alcohol consumption, drug use, psychiatric conditions, social conditions, or occupational conditions that in the opinion of the investigator would preclude compliance with the trial.\n* Receipt of any live vaccines 30 days before or plans to receive any live vaccines 30 days after vaccination.\n* Receipt of any inactivated vaccines 14 days before or plans to receive any inactivated vaccines 14 days after vaccination.\n\nFor participants randomized to the statin therapy + QIV group:\n\n* The participant is currently taking any medication that has known interactions with statin therapy.\n* History of renal or hepatic impairment.\n* Abnormal Safety lab results >1.5 upper limit normal (ULN)",
    "miscellaneous_criteria": ""
}